GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Price-to-Free-Cash-Flow

ABL Bio (XKRX:298380) Price-to-Free-Cash-Flow : N/A (As of Jun. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Price-to-Free-Cash-Flow?

As of today (2024-06-20), ABL Bio's share price is ₩22000.00. ABL Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,405.36. Hence, ABL Bio's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for ABL Bio's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 8 years, ABL Bio's highest Price-to-Free-Cash-Flow Ratio was 244.24. The lowest was 13.75. And the median was 27.53.

XKRX:298380's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.435
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

ABL Bio's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₩-399.73. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩-1,405.36.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of ABL Bio was -919.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 11.90% per year.

During the past 8 years, ABL Bio's highest 3-Year average Free Cash Flow per Share Growth Rate was 72.00% per year. The lowest was -35.40% per year. And the median was -6.65% per year.


ABL Bio Price-to-Free-Cash-Flow Historical Data

The historical data trend for ABL Bio's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Price-to-Free-Cash-Flow Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - 16.08 -

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.21 235.05 - - -

Competitive Comparison of ABL Bio's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, ABL Bio's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Bio's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABL Bio's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ABL Bio's Price-to-Free-Cash-Flow falls into.



ABL Bio Price-to-Free-Cash-Flow Calculation

ABL Bio's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=22000.00/-1405.356
=N/A

ABL Bio's Share Price of today is ₩22000.00.
ABL Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,405.36.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

ABL Bio  (XKRX:298380) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


ABL Bio Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ABL Bio's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio (XKRX:298380) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines